HitGen Inc. (SHA:688222)
24.93
-0.68 (-2.66%)
At close: Sep 19, 2025
HitGen Revenue
HitGen had revenue of 120.28M CNY in the quarter ending June 30, 2025, with 37.71% growth. This brings the company's revenue in the last twelve months to 459.28M, up 11.91% year-over-year. In the year 2024, HitGen had annual revenue of 426.99M with 14.99% growth.
Revenue (ttm)
459.28M
Revenue Growth
+11.91%
P/S Ratio
21.68
Revenue / Employee
933.49K
Employees
483
Market Cap
9.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 426.99M | 55.66M | 14.99% |
Dec 31, 2023 | 371.32M | 41.67M | 12.64% |
Dec 31, 2022 | 329.65M | 18.59M | 5.98% |
Dec 31, 2021 | 311.06M | 67.46M | 27.69% |
Dec 31, 2020 | 243.60M | -20.60M | -7.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |